<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.ajmc.com/view/cemiplimab-response-tied-to-longer-quality-of-life-benefit-in-ansclc</loc>
      <lastmod>2026-11-22T15:30:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-22T15:30:00Z</news:publication_date>
        <news:title><![CDATA[Cemiplimab Response Tied to Longer Quality-of-Life Benefit in aNSCLC]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/acne-treatment-adherence-ranges-from-6-to-84-in-real-world-studies-review-finds</loc>
      <lastmod>2026-11-21T18:45:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-21T18:45:00Z</news:publication_date>
        <news:title><![CDATA[Acne Treatment Adherence Ranges From 6% to 84% in Real-World Studies]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/value-based-pilot-for-medicaid-members-with-substance-use-disorder</loc>
      <lastmod>2026-11-21T17:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-21T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Value-Based Pilot for Medicaid Members With Substance Use Disorder]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/preventing-high-cost-failure-a-value-based-approach-to-reducing-diabetic-limb-loss-in-us-managed-care</loc>
      <lastmod>2026-11-21T14:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-21T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Preventing High-Cost Failure: A Value-Based Approach to Reducing Diabetic Limb Loss in US Managed Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-pimicotinib-for-symptomatic-tenosynovial-giant-cell-tumor</loc>
      <lastmod>2026-11-20T23:05:54.628Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T23:05:54.628Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/real-world-brexu-cel-results-in-mcl-mirror-trials-cost-qol-data-lag</loc>
      <lastmod>2026-11-20T21:54:34.981Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T21:54:34.981Z</news:publication_date>
        <news:title><![CDATA[Real-World Brexu-cel Results in MCL Mirror Trials; Cost, QOL Data Lag]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/health-equity-access-weekly-roundup-november-20-2026</loc>
      <lastmod>2026-11-20T21:52:25.786Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T21:52:25.786Z</news:publication_date>
        <news:title><![CDATA[Health Equity & Access Weekly Roundup: November 20, 2026]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/four-ways-to-boost-awareness-access-for-covid-19-pep</loc>
      <lastmod>2026-11-20T21:00:35.764Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T21:00:35.764Z</news:publication_date>
        <news:title><![CDATA[Four Ways to Boost Awareness, Access for COVID-19 PEP]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/why-early-therapy-matters-in-resistant-gram-negative-lung-infections</loc>
      <lastmod>2026-11-20T20:11:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T20:11:00Z</news:publication_date>
        <news:title><![CDATA[Why Early Therapy Matters in Resistant Gram-Negative Lung Infections]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bridging-the-divide-unveiling-an-opportunity-for-biosimilar-development</loc>
      <lastmod>2026-11-20T17:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>AJMC</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Bridging the Divide: Unveiling an Opportunity for Biosimilar Development]]></news:title>
      </news:news>
	</url></urlset>